ClariTrial | Search Clinical Trials

Explore/atopic dermatitis

Status

Phase

Pre-filtered to show active, later-stage trials with the strongest clinical signal.

229 results for “atopic dermatitis” · Recruiting

Page 1 of 16

Recruiting

Dietary Intervention on Atopy

N/AAtopic DermatitisAtopicAllergic Diseases

Dietary Intervention on Atopy

National University of Singapore110 participants1 site · SingaporeCompletes Dec 2027

Compare CT.gov Full analysis →

Recruiting

Studies of Skin Microbes in Healthy People and in People With Skin Conditions

N/AEczemaAtopic Dermatitis

National Human Genome Research Institute (NHGRI)530 participants1 site · United States

Compare CT.gov Full analysis →

Recruiting

The Role of NIchel and LTPs Sensitization in Functional Gastrointestinal Disorders: the NILT Study

N/AFood Allergy in Children

Federico II University100 participants1 site · ItalyCompletes Jul 2027

Compare CT.gov Full analysis →

Recruiting

Efficacy and Safety of Methotrexate Versus Placebo in Adults With Atopic Dermatitis.

Phase 3Moderate to Severe Atopic Dermatitis

MethotrexatePlacebo

medac GmbH277 participants30 sites · Czechia, France, ItalyCompletes Nov 2026

Compare CT.gov Full analysis →

Recruiting

A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis

Phase 3Atopic Dermatitis

UpadacitinibDupilumab

AbbVie675 participants148 sites · United States, Argentina, AustraliaCompletes Jul 2030

Compare CT.gov Full analysis →

Recruiting

A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atopic Dermatitis

Phase 3Atopic Dermatitis

Tapinarof cream, 1%Vehicle Cream

Organon and Co180 participants46 sites · United States, CanadaCompletes Jan 2028

Compare CT.gov Full analysis →

Recruiting

Reducing Itch With Hypnosis and Virtual Reality

N/AITCHPruritus

Virtual Reality-assisted hypnosis

Universiteit Leiden30 participants1 site · NetherlandsCompletes Dec 2026

Compare CT.gov Full analysis →

Recruiting

A Study to Compare the Pharmacokinetics, Pharmacodynamic, Immunogenicity, and Safety of CKD-706 With US-Dupixent®, and EU-Dupixent® in Healthy Adult Participants.

Phase 1Atopic Dermatitis

CKD-706US-DupixentEU-Dupixent

Chong Kun Dang Pharmaceutical519 participants2 sites · Germany, United KingdomCompletes Nov 2026

Compare CT.gov Full analysis →

Recruiting

Phase 1a/1b Study of TRB-061 in Healthy Participants & Patients With Atopic Dermatitis

Phase 1Moderate-to-severe Atopic Dermatitis

TRB-061TRB-061TRB-061+1 more

TRex Bio, Inc.115 participants15 sites · Australia, New ZealandCompletes Sep 2027

Compare CT.gov Full analysis →

Recruiting

Hydrolysed Rice Formula Study

N/ACow's Milk Protein Allergy

Hydrolysed Rice Protein FormulaCow's Milk Based Extensively Hydrolysed Formula

Nutricia UK Ltd86 participants2 sites · United KingdomCompletes Jul 2027

Compare CT.gov Full analysis →

Recruiting

Evaluate Efficacy and Safety of Repeat Subcutaneous Doses of FB825 in Adults With Moderate-to-Severe Atopic Dermatitis

Phase 2Atopic Dermatitis

FB825Placebo

Oneness Biotech Co., Ltd.114 participants16 sites · United States, TaiwanCompletes May 2027

Compare CT.gov Full analysis →

Recruiting

Ethnic Differences in Mechanisms of Action of Dupilumab

Phase 4Atopic Dermatitis

Dupilumab

University of Michigan30 participants1 site · United StatesCompletes Dec 2026

Compare CT.gov Full analysis →

Recruiting

Phase 2 Randomized Double-blind Study to Assess Topical Zabalafin Hydrogel Vs Vehicle in Mild to Moderate AD.

Phase 2Atopic Dermatitis (Eczema)Atopic Dermatitis EczemaAtopic Dermatitis

zabalafin

Alphyn Biologics72 participants12 sites · AustraliaCompletes Oct 2025

Compare CT.gov Full analysis →

Recruiting

Molecular Signatures of Cutaneous Dupilumab Response

Phase 4Atopic Dermatitis

Dupilumab

University of California, San Francisco15 participants1 site · United StatesCompletes Feb 2028

Compare CT.gov Full analysis →

Recruiting

A Study of SKB575 (HBM7575) Injection in Healthy Participants and Atopic Dermatitis Participants

Phase 1Atopic Dermatitis

SKB575 Injection/SKB575 Placebo

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.90 participants2 sites · ChinaCompletes Dec 2027

Compare CT.gov Full analysis →

1–15 of 229

Explore/atopic dermatitis

Status

Phase

Pre-filtered to show active, later-stage trials with the strongest clinical signal.

229 results for “atopic dermatitis” · Recruiting

Page 1 of 16

Recruiting

Dietary Intervention on Atopy

N/AAtopic DermatitisAtopicAllergic Diseases

Dietary Intervention on Atopy

National University of Singapore110 participants1 site · SingaporeCompletes Dec 2027

Compare CT.gov Full analysis →

Recruiting

Studies of Skin Microbes in Healthy People and in People With Skin Conditions

N/AEczemaAtopic Dermatitis

National Human Genome Research Institute (NHGRI)530 participants1 site · United States

Compare CT.gov Full analysis →

Recruiting

The Role of NIchel and LTPs Sensitization in Functional Gastrointestinal Disorders: the NILT Study

N/AFood Allergy in Children

Federico II University100 participants1 site · ItalyCompletes Jul 2027

Compare CT.gov Full analysis →

Recruiting

Efficacy and Safety of Methotrexate Versus Placebo in Adults With Atopic Dermatitis.

Phase 3Moderate to Severe Atopic Dermatitis

MethotrexatePlacebo

medac GmbH277 participants30 sites · Czechia, France, ItalyCompletes Nov 2026

Compare CT.gov Full analysis →

Recruiting

Phase 3Atopic Dermatitis

UpadacitinibDupilumab

AbbVie675 participants148 sites · United States, Argentina, AustraliaCompletes Jul 2030

Compare CT.gov Full analysis →

Recruiting

A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atopic Dermatitis

Phase 3Atopic Dermatitis

Tapinarof cream, 1%Vehicle Cream

Organon and Co180 participants46 sites · United States, CanadaCompletes Jan 2028

Compare CT.gov Full analysis →

Recruiting

Reducing Itch With Hypnosis and Virtual Reality

N/AITCHPruritus

Virtual Reality-assisted hypnosis

Universiteit Leiden30 participants1 site · NetherlandsCompletes Dec 2026

Compare CT.gov Full analysis →

Recruiting

A Study to Compare the Pharmacokinetics, Pharmacodynamic, Immunogenicity, and Safety of CKD-706 With US-Dupixent®, and EU-Dupixent® in Healthy Adult Participants.

Phase 1Atopic Dermatitis

CKD-706US-DupixentEU-Dupixent

Chong Kun Dang Pharmaceutical519 participants2 sites · Germany, United KingdomCompletes Nov 2026

Compare CT.gov Full analysis →

Recruiting

Phase 1a/1b Study of TRB-061 in Healthy Participants & Patients With Atopic Dermatitis

Phase 1Moderate-to-severe Atopic Dermatitis

TRB-061TRB-061TRB-061+1 more

TRex Bio, Inc.115 participants15 sites · Australia, New ZealandCompletes Sep 2027

Compare CT.gov Full analysis →

Recruiting

Hydrolysed Rice Formula Study

N/ACow's Milk Protein Allergy

Hydrolysed Rice Protein FormulaCow's Milk Based Extensively Hydrolysed Formula

Nutricia UK Ltd86 participants2 sites · United KingdomCompletes Jul 2027

Compare CT.gov Full analysis →

Recruiting

Evaluate Efficacy and Safety of Repeat Subcutaneous Doses of FB825 in Adults With Moderate-to-Severe Atopic Dermatitis

Phase 2Atopic Dermatitis

FB825Placebo

Oneness Biotech Co., Ltd.114 participants16 sites · United States, TaiwanCompletes May 2027

Compare CT.gov Full analysis →

Recruiting

Ethnic Differences in Mechanisms of Action of Dupilumab

Phase 4Atopic Dermatitis

Dupilumab

University of Michigan30 participants1 site · United StatesCompletes Dec 2026

Compare CT.gov Full analysis →

Recruiting

Phase 2 Randomized Double-blind Study to Assess Topical Zabalafin Hydrogel Vs Vehicle in Mild to Moderate AD.

Phase 2Atopic Dermatitis (Eczema)Atopic Dermatitis EczemaAtopic Dermatitis

zabalafin

Alphyn Biologics72 participants12 sites · AustraliaCompletes Oct 2025

Compare CT.gov Full analysis →

Recruiting

Molecular Signatures of Cutaneous Dupilumab Response

Phase 4Atopic Dermatitis

Dupilumab

University of California, San Francisco15 participants1 site · United StatesCompletes Feb 2028

Compare CT.gov Full analysis →

Recruiting

A Study of SKB575 (HBM7575) Injection in Healthy Participants and Atopic Dermatitis Participants

Phase 1Atopic Dermatitis

SKB575 Injection/SKB575 Placebo

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.90 participants2 sites · ChinaCompletes Dec 2027

Compare CT.gov Full analysis →

1–15 of 229